| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/03/2009 | WO2008120202A9 Antibodies, methods and kits for diagnosing and treating melanoma |
| 09/03/2009 | WO2008110912A8 Fertility regulation in horses |
| 09/03/2009 | US20090221953 Composition comprising protein-liposome complex for iontophoresis |
| 09/03/2009 | US20090221718 Metadherin polypeptides, encoding nucleic acids and methods of use |
| 09/03/2009 | US20090221676 Glucose-transport related genes, polypeptides, and methods of use thereof |
| 09/03/2009 | US20090221497 Immunodynamic complexes and methods for using and preparing such complexes |
| 09/03/2009 | US20090221040 immunizing an animal with a mixture of different histidine fusion polypeptides and obtaining polyclonal antibodies directed against the histidine portion of the fusion polypeptides from the serum of the animal; rapid |
| 09/03/2009 | US20090221036 Recombinant anti-cd4 antibodies for human therapy |
| 09/03/2009 | US20090221007 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen |
| 09/03/2009 | US20090221006 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen |
| 09/03/2009 | US20090220607 Polymeric compositions and methods of making and using thereof |
| 09/03/2009 | US20090220586 Proteomimetic compounds as inhibitors of the interaction of nuclear receptor with coactivator peptides |
| 09/03/2009 | US20090220582 Method of cancer treatment using sirna silencing |
| 09/03/2009 | US20090220572 Injectable Combination Therapy for Eye Disorders |
| 09/03/2009 | US20090220568 Methods for treating a stricture with a botulinum toxin |
| 09/03/2009 | US20090220564 Methods of treating and preventing acute myocardial infarction |
| 09/03/2009 | US20090220553 Composition and Method for Inhibiting, Preventing, or Ameliorating Complications Associated With Ingestion of a Medicinal, Chemical, or Biological Substance or Agent |
| 09/03/2009 | US20090220551 Concurrent chemotherapy and immunotherapy |
| 09/03/2009 | US20090220550 Vaccines for Mycoplasma bovis and methods of use |
| 09/03/2009 | US20090220549 Reagents for recombinogenic engineering and use thereof |
| 09/03/2009 | US20090220548 Immunogenic Agents Against Burkholderia Psudomallei And/Or Burkholderia Mallei, Comprising Lipopolysaccharide, Capsular Polysaccharide And/Or Proteins From Burkholderia Pseudomallei |
| 09/03/2009 | US20090220547 Reducing interference between oil-containing adjuvants and surfactant-containing antigens |
| 09/03/2009 | US20090220546 Adjuvanted influenza vaccines for pediatric use |
| 09/03/2009 | US20090220545 Adjuvant-Sparing Multi-Dose Influenza Vaccination Regimen |
| 09/03/2009 | US20090220544 Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture |
| 09/03/2009 | US20090220543 Expression of Proteins in Plants |
| 09/03/2009 | US20090220542 Vaccine comprised specifically of protein subunits of human immunodeficiency virus's glycoprotein 120 probe to prevent and treat an infection caused by the human immunodeficiency virus |
| 09/03/2009 | US20090220541 Emulsions with free aqueous-phase surfactant for adjuvanting split influenza vaccines |
| 09/03/2009 | US20090220540 Helicobacter System and Uses Thereof |
| 09/03/2009 | US20090220539 Recombinant Mononegaviral Virus Vectors |
| 09/03/2009 | US20090220538 vaccine for staphylococcal infections |
| 09/03/2009 | US20090220537 Vaccine delivery system |
| 09/03/2009 | US20090220536 HIV vaccine immunogens and immunization strategies to elicit broadly-neutralizing anti-HIV-1 antibodies against the membrane proximal domain of HIV GP41 |
| 09/03/2009 | US20090220535 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection |
| 09/03/2009 | US20090220534 Methods for identifying t-cell epitopes associated with impaired peptide processing and applications of the identified epitopes |
| 09/03/2009 | US20090220533 Novel T-Helper Antigenic Determinant (THD) Peptides |
| 09/03/2009 | US20090220532 Agents and methods based on the use of the eda domian of fibronectin |
| 09/03/2009 | US20090220531 Composition of which Chief Ingredient is Polysaccharides Having an Immunoregulatory Function |
| 09/03/2009 | US20090220530 Defective ribosomal products in blebs (dribbles) and methods of use to stimulate an immune response |
| 09/03/2009 | US20090220529 Anticancer Drugs Conjugated to Antibody via an Enzyme Cleavable Linker |
| 09/03/2009 | US20090220528 Stimulation of Toll-Like Receptors on T Cells |
| 09/03/2009 | US20090220527 Affinity optimized epha2 agonistic antibodies and methods of use thereof |
| 09/03/2009 | US20090220526 Acute renal injury |
| 09/03/2009 | US20090220525 Novel Bacterium and Vaccine |
| 09/03/2009 | US20090220524 Therapeutic agents for alzheimer's disease and cancer |
| 09/03/2009 | US20090220523 Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions |
| 09/03/2009 | US20090220522 Detoxified Endotoxin Vaccine and Adjuvant and Uses thereof |
| 09/03/2009 | US20090220521 Anti MIF Antibodies |
| 09/03/2009 | US20090220520 Recombinant method for the production of a monoclonal antibody to CD52 for the treatment of chronic lymphocytic leukemia |
| 09/03/2009 | US20090220519 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 09/03/2009 | US20090220518 Methods and compositions for treatment of graft rejection and promotion of graft survival |
| 09/03/2009 | US20090220517 Method for producing epitomers and their uses on carrier microorganisms |
| 09/03/2009 | US20090220516 Neuroprotection of retinal ganglion cells |
| 09/03/2009 | US20090220515 Treatment and prevention of renal disease |
| 09/03/2009 | US20090220514 ADAM10 and its Uses Related to Infection |
| 09/03/2009 | US20090220513 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 09/03/2009 | US20090220512 Genes and polypeptides relating to prostate cancers |
| 09/03/2009 | US20090220511 human polypeptides named IFN (interferon)- lambda 1, IFN- lambda 2 and IFN- lambda 3 and IFN- lambda R1; antiviral agents |
| 09/03/2009 | US20090220510 Recognize aberrant glycosylated form of the EGFR; evident upon aberrant post-translational modification; cancer |
| 09/03/2009 | US20090220509 Singlec-9 binding agents |
| 09/03/2009 | US20090220508 Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement |
| 09/03/2009 | US20090220507 Inhibition of extracellular signal-regulated kinase 1/2 as a treatment for cardiac hypertrophy and heart failure |
| 09/03/2009 | US20090220506 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 09/03/2009 | US20090220505 Methods of inhibiting amyloid toxicity |
| 09/03/2009 | US20090220504 Combinatorial therapy |
| 09/03/2009 | US20090220503 Method for treating cancers with increased ras signaling |
| 09/03/2009 | US20090220502 B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS |
| 09/03/2009 | US20090220501 Anti-CD19 Antibody, Immunotoxin and Treatment Method |
| 09/03/2009 | US20090220500 Agents for treating cardiopathy |
| 09/03/2009 | US20090220499 Agents for Suppressing Damage to Transplanted Islets After Islet Transplantation |
| 09/03/2009 | US20090220498 Method for Discovering Inhibitors of the Epstein-Barr Virus-Induced Gene 3 (EBI3) and Derivatives Thereof for the Treatment of Metastasizing Tumors and Allergic Asthma |
| 09/03/2009 | US20090220497 Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment |
| 09/03/2009 | US20090220496 Novel uses for anti-ige therapy |
| 09/03/2009 | US20090220495 Cancer Related Genes (PRLR) |
| 09/03/2009 | US20090220494 Antibodies produced in a transgenic avian |
| 09/03/2009 | US20090220493 Reagents and methods for inducing an immune response to prostate specific antigen |
| 09/03/2009 | US20090220492 Protein purification |
| 09/03/2009 | US20090220491 Binding agents which inhibit myostatin |
| 09/03/2009 | US20090220490 Compositions and Assays for Inhibiting HCV Infection |
| 09/03/2009 | US20090220489 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| 09/03/2009 | US20090220488 Evaluating and treating scleroderma |
| 09/03/2009 | US20090220487 via blocking proteins and signal transduction pathways, with peptide which inhibits p21-activated kinase (PAK)-PIX-GIT interaction or complex formation; mitogen-activated protein kinase inhibitors; tissue damage, ischemia, inflammation, stroke, wound healing, acute respiratory distress syndrome |
| 09/03/2009 | US20090220486 Antibodies and uses thereof |
| 09/03/2009 | US20090220485 Method for isolation of soluble polypeptides |
| 09/03/2009 | US20090220484 Rage/Diaphanous Interaction and Related Compositions and Methods |
| 09/03/2009 | US20090220455 Pharmaceutical compositions comprising elp fusion proteins |
| 09/03/2009 | US20090220452 Method Of Producing A Modified (POLY) Peptide |
| 09/03/2009 | US20090220435 Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents |
| 09/03/2009 | US20090220424 Pro104 Antibody Compositions and Methods of Use |
| 09/03/2009 | US20090220417 Methods of using il-31 monoclonal antibodies to reduce inflammation |
| 09/03/2009 | US20090220416 Immunoglobulin associated cell-surface determinants in the treatment of b-cell disorders |
| 09/03/2009 | CA2717038A1 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 09/03/2009 | CA2716622A1 Glycopeptides and methods of making and using them |
| 09/03/2009 | CA2715456A1 Monoclonal antibodies against the rgm a protein and uses thereof |
| 09/03/2009 | CA2714720A1 Antibodies to clostridium difficile spores and uses thereof |
| 09/02/2009 | EP2096122A1 Anti-human dlk-1 antibody showing anti-tumor activity in vivo |
| 09/02/2009 | EP2096120A2 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 09/02/2009 | EP2095873A1 Isolation of immunoglobulins |
| 09/02/2009 | EP2095827A1 High affinity human monoclonal antibodies specific for RSV F-protein |
| 09/02/2009 | EP2095826A1 Nerve elongation promoter and elongation inhibitor |